跳至主要内容
临床试验/NCT06508073
NCT06508073已完成不适用

Neural Therapy in Notalgia Paresthetica

Sisli Hamidiye Etfal Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2024年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
Short Form-12 for Quality of life

研究概览

简要总结

Patients diagnosed with Notalgia paresthetica and who received neural therapy within the last year were retrospectively screened. In the evaluations before treatment and at the 3rd month after treatment; Numerical rating scale for pain, PainDETECT questionnaire for neuropathic pain, SF-12 for quality of life and 5-D itch scale for itch level were used.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • the presence of a hyperpigmented skin lesion consistent with NP
  • minimum 6 months for duration of disease
  • 30-60 aged
  • application of neural therapy in a manner appropriate to the diagnosis

排除标准

  • history of previous surgery or injection in the thoracic region
  • presence of another treatment in the same period
  • presence of any cardiac or pulmonary disease, malignancy, or advanced psychiatric disease

结局指标

主要结局

Short Form-12 for Quality of life

时间窗: 12 weeks after treatment

The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.

Numeric Rating Scale for Pain

时间窗: 12 weeks after treatment

A scale between 0 and 10 was used to question the pain level.

PainDETECT Questionnaire for assessing Neuropathic pain

时间窗: 12 weeks after treatment

The questionnaire consists of 9 items and is completed by the patient (no clinical examination is required)\[1\]\[3\]. There are 7 weighted sensory descriptor items (never to very strongly) and 2 items relating to spatial and temporal pain characteristics\[3\]. A total score of 19 or more is indicative of likely neuropathic pain.

5-D Itch Scale

时间窗: 12 weeks after treatment

The 5-D itch scale is a 5-domain disease-specific instrument evaluating the duration, degree (severity), direction (improving, unaltered or worsening), disability (impact on sleep, leisure/social, housework/errands and school/work activities) and distribution (body part affected)

次要结局

未报告次要终点

研究者

发起方
Sisli Hamidiye Etfal Training and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aylin Ayyıldız

Medical Doctor

Sisli Hamidiye Etfal Training and Research Hospital

研究点 (1)

Loading locations...

相似试验